Mohamed-Abdel-Al-Sayed-header

The WFH in Egypt: Mohamed’s story

The World Federation of Hemophilia (WFH) has been active in the Egyptian bleeding disorders community since early 2000. In the nearly 24 years since then, the WFH has worked with stakeholders through many programs, including the WFH Global Alliance for Progress (GAP) program, the WFH Path to Access to Care and Treatment (PACT) Program, the International Hemophilia Training Centre (IHTC) Fellowship Program, the WFH Twinning Program, and the WFH Humanitarian Aid Program.

Also available in: Français Español

Next month, we will be publishing an article on the work that the WFH has done in Egypt over the last two decades, including the recent signing of a memorandum of understanding (MOU). Today, we hear from Mohamed Abdel-Al Sayed, a 29-year-old man with severe hemophilia A who has benefitted from WFH Humanitarian Aid Program support. His letter has been edited for clarity.

Hello WFH,

I am Mohamed Abdel-Al Sayed, 29 years old. I was diagnosed with hemophilia when I was three months old. My whole life I have lived on plasma and cryoprecipitate. One day I felt a very severe pain at my right lower abdomen. Unfortunately, there was internal bleeding that happened without any warning. I went to the El-Demerdash Hospital at 2 o’clock at night, hoping that they would treat me with plasma. Unfortunately, they told me that they could not provide me with any replacement treatment. The bleeding continued to increase inside my stomach.

I waited until the morning to be examined in the hematology clinic. The doctor, the first time she saw me, referred me to surgery. The bleeding increased. My blood pressure dropped so much that I was dizzy. I started fainting. My heart stopped twice. I fainted, and when I woke up, I found myself in intensive care. An exploratory operation had been performed and my abdomen was opened with about twenty stitches. The surgeons had to open it to stop the bleeding.

My condition was very critical, and my family approached the Egyptian Society of Hemophilia to ask for a consultation and treatment. Thank God they responded quickly and contacted the surgery team. They gave the hospital donated treatment product provided by the WFH Humanitarian Aid Program.

I’m so grateful to the WFH. I became better. For about a month, I was in the hospital for post operative care where I was supported by prophylactic management. If it was not for this support my wound would not have been closed, nor would I be in good condition now. I hope that the WFH Humanitarian Aid Program aid continues and helps more people.

March 2024

Mohamed Abdel-Al Sayed

The WFH Humanitarian Aid Program has been active in Egypt for over a decade, with 94.6 million IUs of factor donated to the country since 2015. Just last year, 25.6 million IUs of factor were donated to Egypt. To find out more about the WFH Humanitarian Aid Program please click here. 

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda and Japan Blood Products Organization, our Contributors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.